News | March 25, 2011

Vital Images and Bayer HealthCare Diagnostics Arrange Collaboration

March 25, 2011 – The diagnostic imaging business unit of Bayer Vital GmbH and Vital Images, have signed a cooperation agreement. The agreement’s objective is to conduct joint activities that will introduce radiologists in Germany to the combination of appropriate software and contrast agents.

“Rapid developments in advanced visualization software used with state-of-the-art MRI and CT imaging techniques are delivering a huge amount of additional information,” said Robert Hite, head of the diagnostic imaging business in Germany. “This is presenting the evaluating radiologists with the challenge of efficiently selecting the right information from the constantly growing volume of image data. Both image processing software and contrast agents greatly assist diagnostic efficiency and when used in tandem could deliver substantial benefits for the evaluating radiologist. If we can coordinate the two techniques better, it could lead to considerable synergies to the benefit of the radiologist.”

“We are excited by our groundbreaking collaboration with Bayer in Germany and feel it will help grow our global business and development activities,” said Michael H. Carrel, CEO Vital Images. “This is a truly unique collaboration involving visualization with contrast agents and we are confident that, with Bayer, we have found the right partner to make this kind of collaboration a success.”

For more information: www.vitalimages.com

Related Content

Study Finds No Evidence that Gadolinium Causes Neurologic Harm

MR images through, A, C, E, basal ganglia and, B, D, F, posterior fossa at level of dentate nucleus. Images are shown for, A, B, control group patient 4, and the, C, D, first and, E, F, last examinations performed in contrast group patient 13. Regions of interest used in quantification of signal intensity are shown as dashed lines for globus pallidus (green), thalamus (blue), dentate nucleus (yellow), and pons (red).

News | Contrast Media | January 11, 2018
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive dec
Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Imaging | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
Videos | Magnetic Resonance Imaging (MRI) | December 19, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
The FDA issued new warnings on MRI gadolinium contrast agents. (GBCAs)

The FDA issued new warnings on MRI gadolinium contrast agents. 

Feature | Magnetic Resonance Imaging (MRI) | December 19, 2017
The U.S.
Brainlab Contrast Clearance Analysis Software Receives FDA 510(k) Clearance
Technology | Contrast Media | December 12, 2017
Brainlab announced U.S. Food and Drug Administration (FDA) clearance of its Contrast Clearance Analysis methodology,...
Sectra Offers Gadolinium Tracking Functionality in DoseTrack Software
Technology | Contrast Media | December 11, 2017
December 11, 2017 — Sectra recently announced the global introduction of gadolinium tracking in its dose monitoring s
Videos | Magnetic Resonance Imaging (MRI) | December 07, 2017
Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, discussed MR
Guerbet to Participate in French Interventional Radiology Conference
News | Contrast Media | October 10, 2017
Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will...
Trends in contrast media used in magnetic resonance imaging and computed tomography

Image courtesy of Bayer

Feature | Contrast Media | October 04, 2017 | By Dave Fornell
Over the past decade, several clinical studies have shown gadolinium-based magnetic resonance imaging (MRI) contrast...
Overlay Init